Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
rare diseases
Pharma
Rhythm's Imcivree posts ph. 3 miss in rare genetic obesities
The company evaluated Imcivree across four genetic-driven obesity subgroups, with the treatment missing the primary BMI endpoint in each substudy.
Zoey Becker
Mar 17, 2026 11:43am
Orphan drug sales to surge past $400B in 2032: report
Mar 12, 2026 8:20am
Spruce hooks a commercial chief to prep for rare disease launch
Mar 9, 2026 1:15pm
Sanofi inks $1.5B deal for Sino Biopharm's novel asset
Mar 4, 2026 3:00am
Acadia pushes for re-review of CHMP's Daybue snub
Mar 3, 2026 11:45am
Fierce Biotech
Disc lays off 20% of workforce in wake of FDA rejection
Mar 3, 2026 10:45am
